INTECH Investment Management’s Capricor Therapeutics CAPR Stock Holding History

INTECH Investment Management’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$412K	Buy	17,114 +2,024	+13%	+$61.4K	﹤0.01%	1425
2026 Q1	$459K	Buy	+15,090	New	+$402K	﹤0.01%	1377
2025 Q4	–	Sell	-17,700	Closed	-$128K	–	2346
2025 Q3	$128K	Sell	17,700 -13,414	-43%	-$98.8K	﹤0.01%	2200
2025 Q2	$309K	Sell	31,114 -9,227	-23%	-$97.5K	﹤0.01%	1850
2025 Q1	$383K	Buy	40,341 +23,795	+144%	+$330K	﹤0.01%	1758
2024 Q4	$228K	Buy	+16,546	New	+$290K	﹤0.01%	1969

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

INTECH Investment Management's CAPR Position: Q2 2026 in Review

INTECH Investment Management increased its Capricor Therapeutics (CAPR) stake by 13% in Q2 2026, buying an estimated $61.4K and bringing the position to 17,114 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #1425.

INTECH Investment Management first reported a position in CAPR in Q4 2024 and has held it in 6 quarters since. The position peaked at $459K in Q1 2026. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

INTECH Investment Management held 17,114 shares of Capricor Therapeutics worth $412K as of Q2 2026.
INTECH Investment Management bought 2,024 Capricor Therapeutics shares in Q2 2026, an estimated $61.4K.
Capricor Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1425 holding.
INTECH Investment Management first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 6 quarters since.
INTECH Investment Management's Capricor Therapeutics position peaked at $459K in Q1 2026.
169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.